Saturday, July 5, 2025

Grapefruit USA, Inc. Announces Formal Execution of its License Agreement with Zylö Therapeutics Inc. Granting Grapefruit an Exclusive License for use of Zylö’s Patented Z-Pod(TM) Delivery System which drives Grapefruit’s Disruptive Hourglass(TM) Time Release THC+Cannabinoid Topical Cream




News Story – QuoteMedia Market Data Solutions




Share: